Their in vivo study found that the transgenic animals expressing human IAPP and mutant APP showed increased Aβ burden in the hippocampus and cortex compared to AD transgenic mice or AD transgenic animals with type 1 diabetes. The gene discussed is IAPP; the disease is Alzheimer disease.